Palbociclib
Pfizer
['palbo', 'palbociclib']
 #asco2023 penelope-b. adjuvant palbociclib v placebo in patients with high relapse risk post neo-adjuvant chemo. small benefit disappears after two years. negative for primary endpoint. ct dna detection predicts risk for early relapse but no therapeutic implications now
Breast med oncology, chief hem/onc @NYPBrooklyn, prof clinical med @WeillCornell, ethics/spirituality in medicine; long time NY #Jets sufferer; tweets my own